|
FUCA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.954600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.249600E-01 |
| Normal-vs-Stage2 |
1.003160E-01 |
| Normal-vs-Stage3 |
3.579400E-01 |
| Normal-vs-Stage4 |
3.942600E-01 |
| Stage1-vs-Stage2 |
1.239800E-01 |
| Stage1-vs-Stage3 |
3.486800E-01 |
| Stage1-vs-Stage4 |
4.179200E-01 |
| Stage2-vs-Stage3 |
2.927000E-01 |
| Stage2-vs-Stage4 |
4.100600E-01 |
| Stage3-vs-Stage4 |
9.135400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.423960E-01 |
| Normal-vs-AfricanAmerican |
3.913000E-01 |
| Normal-vs-Asian |
5.626400E-01 |
| Caucasian-vs-AfricanAmerican |
1.875780E-01 |
| Caucasian-vs-Asian |
4.453800E-01 |
| AfricanAmerican-vs-Asian |
8.490800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.824200E-02 |
| Normal-vs-Female |
2.069000E-01 |
| Male-vs-Female |
2.921000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.659000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.218600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.625800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.295400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.940000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.145600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.763000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.454800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.416200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.204600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.151200E-01 |
| Normal-vs-Grade 2 |
7.426200E-01 |
| Normal-vs-Grade 3 |
3.311200E-01 |
| Normal-vs-Grade 4 |
2.792400E-01 |
| Grade 1-vs-Grade 2 |
2.915400E-01 |
| Grade 1-vs-Grade 3 |
2.433000E-01 |
| Grade 1-vs-Grade 4 |
2.170400E-01 |
| Grade 2-vs-Grade 3 |
5.095600E-01 |
| Grade 2-vs-Grade 4 |
3.924800E-01 |
| Grade 3-vs-Grade 4 |
7.528600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.357800E-01 |
| Normal-vs-ccB subtype |
2.936300E-02 |
| ccA subtype-vs-ccB subtype |
1.475180E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.392800E-01 |
| Normal-vs-N1 |
1.795220E-01 |
| N0-vs-N1 |
1.248760E-01 |
|
|
